Jump to top navigation | Jump to main navigation | Jump to content
Therapeutic Goods Administration logo

Glossary of terms, definitions & acronyms

The following terms, definitions & acronyms are used in Australian therapeutic goods regulation. They are provided as general information only and this is not intended to be an exhaustive list.

Refer to Australian therapeutic goods legislation for legal definitions and for other terms not included on this page.

A

AAN

Australian approved names (see TGA approved terminology for medicines)

ABN

Australian Business Number or Australian Biological Name (see TGA approved terminology for medicines)

[the] Act

the Therapeutic Goods Act 1989

active implantable medical device (AIMD)

an active medical device (other than an implantable medical device) that is intended by the manufacturer:

  1. either:
    1. to be, by surgical or medical intervention, introduced wholly, or partially, into the body of a human being; or
    2. to be, by medical intervention, introduced into a natural orifice in the body of a human being; and
  2. to remain in place after the procedure.

active ingredient

the therapeutically active component in a medicine's final formulation that is responsible for its physiological action

active medical device

  1. a medical device that is intended by the manufacturer:
    1. to depend for its operation on a source of electrical energy or other source of energy (other than a source of energy generated directly by a human being or gravity); and
    2. to act by converting this energy; but
  2. does not include a medical device that is intended by the manufacturer to transmit energy, a substance, or any other element, between an active medical device and a human being without any significant change in the energy, substance or other element being transmitted

active pharmaceutical ingredient (API)

therapeutically active component in the final formulation of therapeutic goods

active raw material

the unformulated active chemical substance, usually a powder or a liquid, in the form in which it is used to manufacture a dosage form, usually in combination with excipients

ADEC

Australian Drug Evaluation Committee

adverse drug reaction (ADR)

see Guidelines on the reporting of adverse drug reactions by drug sponsors: Definitions

ADRAC

Adverse Drug Reactions Advisory Committee

advertisement

any statement, pictorial representation or design, however made, that is intended, whether directly or indirectly, to promote the use or supply of the goods (also see Advertising therapeutic products in Australia)

adverse event (AE)

see Guidelines on the reporting of adverse drug reactions by drug sponsors: Definitions

AHMAC

Australian Health Ministers' Advisory Council

AHN

Australian Herbal Name (see TGA approved terminology for medicines)

AHS

Australian herbal substance

AIVC

Australian Influenza Vaccine Committee

antiseptic

a substance:

  1. that is recommended by its manufacturer for:
    1. dermal application; or
    2. application to the mucous membranes of a person or an animal:
      1. to kill micro organisms; or
      2. to prevent the growth of micro organisms to a level that causes or may cause clinical infection; and
  2. that is not represented to be suitable for internal use.

ANZTPA

Australia New Zealand Therapeutic Products Authority

APVMA

Australian Pesticides and Veterinary Medicines Authority

ARGCM

Australian Regulatory Guidelines for Complementary Medicines

ARGMD

Australian Regulatory Guidelines for Medical Devices

ARGOM

Australian Regulatory Guidelines for OTC Medicines

ARGPM

Australian Regulatory Guidelines for Prescription Medicines

ARTG

Australian Register of Therapeutic Goods

AUST L number

the unique ARTG number for a listed therapeutic product (also see: Buying medicines - What's on the label for me?)

AUST R number

the unique ARTG number for a registered therapeutic product (also see: Buying medicines - What's on the label for me?)

Top of page

B

batch

a quantity of a product that is:

  1. uniform in composition, method of manufacture and probability of chemical or microbial contamination; and
  2. made in one cycle of manufacture and, in the case of a product that is sterilised or freeze dried, sterilised or freeze dried in one cycle

BP

British Pharmacopoeia (see Definition of 'British Pharmacopoeia' in the Therapeutic Goods Act 1989)

broadcast media

in relation to an advertisement or generic information, means any means (other than a means declared in the regulations to be an exempted means) by which the information is disseminated electronically in a visible or audible form or a combination of such forms

BSE

bovine spongiform encephalopathy (see Transmissible spongiform encephalopathies (TSEs))

Top of page

C

category A patient

a person who is seriously ill with a condition from which death is reasonably likely to occur within a matter of months, or from which premature death is reasonably likely to occur in the absence of early treatment (see Special Access Scheme)

category B patient

all other patients that do not fit the Category A definition (see Special Access Scheme)

CHMP

European Medicines Agency Committee for Medicinal Products for Human Use

Client ID

identification code assigned by the TGA to a client (see Client details form)

clinical trial

a planned study in humans designed to investigate or report upon the effectiveness and/or safety of a therapeutic good

CLP

Certificate of Listed Product

CMEC

Complementary Medicines Evaluation Committee

complementary medicine

therapeutic goods consisting wholly or principally of one or more designated active ingredients, each or which has a clearly established identity and

  1. a traditional use OR
  2. any other use prescribed in the regulations

Schedule 14 of the Therapeutic Goods Regulations 1990 defines the following as 'designated active ingredients':

  1. an amino acid
  2. charcoal
  3. a choline salt
  4. an essential oil
  5. plant or herbal material (or a synthetically produced substitute for material of that kind), including plant fibres, enzymes, algae, fungi, cellulose and derivatives of cellulose and chlorophyll
  6. a homoeopathic preparation
  7. a microorganism, whole or extracted, except a vaccine
  8. a mineral including a mineral salt and a naturally occurring mineral
  9. a mucopolysaccharide
  10. non-human animal material (or a synthetically produced substitute for material of that kind) including dried material, bone and cartilage, fats and oils and other extracts or concentrates
  11. a lipid, including an essential fatty acid or phospholipid
  12. a substance produced by or obtained from bees, including royal jelly, bee pollen and propolis
  13. a sugar, polysaccharide or carbohydrate
  14. a vitamin or provitamin

composite pack [medical devices]

see Australian Regulatory Guidelines for Medical Devices

composite pack [medicine]

a medicinal product where the primary pack or the container includes at least two kinds of medicinal products and does not contain any medical devices. The medicinal products must be for use as a single treatment or as a single course of treatment, and it is necessary that the medicines be combined before administration or that they must be administered in a particular sequence

Examples:

  • a strip or blister pack containing tablets or capsules with differing formulations to be taken in a specified order
  • a primary pack containing an active ingredient in one vial and a diluent in another vial
  • a primary pack containing separate containers of different formulations for use as part of a single regimen of treatment

conformity assessment

see Australian Regulatory Guidelines for Medical Devices

Consumer Medicine Information (CMI)

document required to be provided to patients with prescription medicines that gives a plain-English explanation of the product

container

in relation to therapeutic goods, means the vessel, bottle, tube, ampoule, syringe, vial, sachet, strip pack, blister pack, wrapper, cover or other similar article that immediately covers the goods, but does not include an article intended for ingestion

CPP

Certificate of Pharmaceutical Product

critical medical device

a device that, when used as recommended by its manufacturer, is in a sterile condition on introduction into the human body

CTD

Common technical document

CTN

Clinical trial notification

CTX

Clinical trial exemption scheme

custom-made medical device

a medical device that:

  1. is specifically made in accordance with a request by a health professional specifying the design characteristics or construction of the medical device; and
  2. is intended to be used only in relation to a particular individual

Top of page

D

DEAL

Device Electronic Application Lodgement

desktop review

The review of GMP documentary evidence for a manufacturer to ascertain an acceptable standard

direct diagnosis

in relation to a patient, means continuous surveillance by direct measurement

directions for use

includes information on:

  1. appropriate uses of the therapeutic goods
  2. the method of administration or use of the goods
  3. the frequency and duration of treatment for each indication of the goods
  4. the use of the goods by persons of particular ages or by persons having particular medical conditions

disinfectant

a substance:

  1. that is recommended by its manufacturer for application to an inanimate object to kill micro organisms; and
  2. that is not represented by the manufacturer to be suitable for internal use

dosage form

the pharmaceutical form in which a product is presented for therapeutic administration, e.g. tablet, cream (see TGA approved terminology for medicines)

Top of page

E

EC-MRA

Australia - European Community mutual recognition agreement

EEL

Export Only [medicines] Lodgement System

EFTA-MRA

Australia - European Free Trade Association mutual recognition agreement

ELF

Electronic Listing Facility

EMEA

European Medicines Agency

EP

European Pharmacopoeia

essential principles

the essential principles set out the requirements relating to the safety and performance characteristics of medical devices (see the Australian Regulatory Guidelines for Medical Devices)

EU

European Union

excipient

any component of a finished dosage form other than an active ingredient

excluded goods

goods which might be considered to be therapeutic goods but which are specifically declared not to be by an Order of the Secretary (and therefore not subject to any requirements of the Act) (also see Therapeutic Goods (Excluded Goods) Order No. 1 of 2008 and Section 7 declarations - food or therapeutic good?

exempt goods

therapeutic goods that are exempted from the requirements to be Registered or Listed, or are exempted from licensing requirements by the Therapeutic Goods Regulations

export name

the proprietary name used for the goods for supply in another country where that name is different from the proprietary name used for the goods for supply in Australia

export only medicine

medicine that:

  1. is manufactured in Australia for export only, or imported into Australia for export only; and
  2. is listable goods only because it is so manufactured or imported (and not for any other reason)

Top of page

F

FDA

USA Food and Drug Administration

finished goods

the finished or final dosage form of the therapeutic good when all stages of manufacture, other than release for sale, have been completed

formulation

a list of the ingredients used in the manufacture of a dosage form and a statement of the quantity of each ingredient in a defined weight, volume, unit or batch

FSANZ

Food Standards Australia New Zealand

Top of page

G

gazetted therapeutic goods group

a group of medicines which have common characteristics, that are identified in an order published in the Commonwealth Government Notices Gazette (see Therapeutic goods (groups) orders)

generic medicine

a medicine that, in comparison to a registered medicine:

  1. has the same quantitative composition of therapeutically active substances, being substances of similar quality to those used in the registered medicine; and
  2. has the same pharmaceutical form; and
  3. is bioequivalent; and
  4. has the same safety and efficacy properties

GHTF

Global Harmonization Task Force

GMDN (Global Medical Device Nomenclature)

a collection of internationally recognised terms used to accurately describe and catalogue medical devices, in particular, those products used in the diagnosis, prevention, monitoring, treatment or alleviation of disease or injury in humans

GMP clearance

The approval of GMP documentary evidence that shows a manufacturer is of an acceptable standard

good manufacturing practice (GMP)

The acronym GMP is used internationally to describe a set of principles and procedures which, when followed by manufacturers of therapeutic goods, helps ensure that the products manufactured will have the required quality. A basic tenet of GMP is that quality cannot be tested into a batch of product but must be built into each batch of product during all stages of the manufacturing process. (Also see: Good manufacturing practice for therapeutic goods)

grouped therapeutic goods

medicines, devices or kits grouped under the one ARTG number (not to be confused with gazetted therapeutic goods group which only refers to medicines)

Top of page

H

HCN

Herbal component name

HCT

Human cellular and tissue therapies

herbal substance

all or part of a plant or substance (other than a pure chemical or a substance of bacterial origin):

  1. that is obtained only by drying, crushing, distilling, extracting, expressing, comminuting, mixing with an inert diluent substance or another herbal substance or mixing with water, ethanol, glycerol or aqueous ethanol; and
  2. that is not subjected to any other treatment or process other than a treatment or process that is necessary for its presentation in a pharmaceutical form

homoeopathic preparations

a preparation:

  1. formulated for use on the principle that it is capable of producing in a healthy person symptoms similar to those which it is administered to alleviate; and
  2. prepared according to the practices of homoeopathic pharmacy using the methods of:
    1. serial dilution and succussion of a mother tincture in water, ethanol, aqueous ethanol or glycerol; or
    2. serial trituration in lactose

(also see Homoeopathic preparations)

HPCs

Haematopoietic progenitor cells

HREC

Human research ethics committee

HRT

Hormone replacement therapy

Top of page

I

ICH

International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use

implantable medical device

a medical device (other than an active implantable medical device) that is intended by the manufacturer:

  1. to be, by surgical intervention, wholly introduced into the body of a human being, and to remain in place after the procedure; or
  2. to replace, by surgical intervention, an epithelial surface, or the surface of an eye, of a human being, and to remain in place after the procedure; or
  3. to be, by surgical intervention, partially introduced into the body of a human being, and to remain in place for at least 30 days after the procedure

included in the Register

in relation to a medical device to which Chapter 4 of the Therapeutic Goods Act 1989 applies, means included in the ARTG

Note: For medical devices to which Chapter 4 applies, see section 41BJ of the Act.

indications

means the specific therapeutic uses of the goods

informed consent

in relation to treatment or proposed treatment, means consent freely given by a person on the basis of information concerning the potential risks and benefits of the treatment that was sufficient information to allow the person to make an informed decision whether to consent to the treatment

intended purpose

of a kind of medical device, means the purpose for which the manufacturer of the device intends it to be used, as stated in:

  1. the information provided with the device; or
  2. the instructions for use of the device; or
  3. any advertising material applying to the device

invasive medical device

a medical device that is intended by the manufacturer to be used, in whole or in part, to penetrate the body of a human being through a body orifice or through the surface of the body

IRIS

Incident Report Investigation Scheme (for medical devices)

ISO

International standard

IVD or IVDD

in vitro diagnostic device

Top of page

J

Top of page

K

kit

Kits are listed as either medicine or device kits. A package and therapeutic goods in the package together constitute a kit for the purposes of the Therapeutic Goods Act 1989 if:

  1. the package and the therapeutic goods are for use as a unit; and
  2. each item of the therapeutic goods consists of goods that are registered or listed or are exempt goods in relation to Part 3-2; and
  3. the package and therapeutic goods do not constitute a composite pack or a system or procedure pack.

Top of page

L

label

means a display of printed information:

  1. on or attached to the goods; or
  2. on or attached to a container or primary pack in which the goods are supplied; or
  3. supplied with such a container or pack

licence

In Australia, the Therapeutic Goods Act 1989 requires, with certain exceptions, that manufacturers of therapeutic goods hold a licence. It is an offence, carrying heavy penalties, to manufacture therapeutic goods for human use without a licence unless the manufacturer or goods are exempt from this requirement.

To obtain a licence to manufacture therapeutic goods, a manufacturer must demonstrate, during a factory audit, compliance with manufacturing principles which includes relevant Codes of GMP and Quality Systems.

listable goods

therapeutic goods that are required by the Act to be included in that part of the ARTG relating to Listed goods

listed goods

therapeutic goods that are included in the part of the ARTG for goods known as Listed goods

listed medicine

see Summary classification of medicines

listing number

see AUST L number

Top of page

M

mainstream media

any magazine or newspaper for consumers containing a range of news, public interest items, advertorials, advertisements or competitions

manufacture

the production of medicines or any part of the process of producing medicines or bringing the goods to their final state, including engaging in the processing, assembling, packaging, labelling, storage, sterilising, testing or releasing for supply of the goods or of any component or ingredient of the goods as part of that process

manufacturer

corporation or person carrying out one or more of the steps specified in the definition of manufacture

manufacturer of a medical device

  1. The manufacturer of a medical device is the person who is responsible for the design, production, packaging and labelling of the device before it is supplied under the person's name, whether or not it is the person, or another person acting on the person's behalf, who carries out those operations.
  2. If subsection (1) does not apply to a medical device, the manufacturer of the device is the person who, with a view to supplying the device under the person's name, does one or more of the following using ready-made products:
    1. assembles the device;
    2. packages the device;
    3. processes the device;
    4. fully refurbishes the device;
    5. labels the device;
    6. assigns to the device its purpose by means of information supplied, by the person, on or in any one or more of the following:
      1. the labelling on the device;
      2. the instructions for using the device;
      3. any advertising material relating to the device.
  3. However, a person is not the manufacturer of a medical device if:
    1. the person assembles or adapts the device for an individual patient; and
    2. the device has already been supplied by another person; and
    3. the assembly or adaptation does not change the purpose intended for the device by means of information supplied by that other person, on or in any one or more of the following:
      1. the labelling on the device;
      2. the instructions for using the device;
      3. any advertising material relating to the device.

manufacturing licence

A licence granted under Part 3-3 of the Act, or a licence granted under a State or Territory law relating to therapeutic goods, relating to manufacturing therapeutic goods

manufacturing certificates

  • Certificate of GMP Compliance
  • GMP Certificate of Manufacturing Facility
  • Certificate of GMP Compliance of a Manufacturer

MDEC

Medical Device Evaluation Committee

medical device

see What is a medical device

medicine

  1. therapeutic goods that are represented to achieve, or are likely to achieve, their principal intended action by pharmacological, chemical, immunological or metabolic means in or on the body of a human or animal
  2. any other therapeutic goods declared by the Secretary, for the purposes of the definition of therapeutic device, not to be therapeutic devices

also see Summary classification of medicines

MEC

Medicines Evaluation Committee

MMF

Manufacturer's Master File

MoI

Memorandum of Intention

mother tincture

a product of the process of solution, extraction or trituration, from which homoeopathic preparations are made

MoU

Memorandum of Understanding

MRA

Mutual Recognition Agreement

Top of page

N

NCCTG

National Coordinating Committee on Therapeutic Goods

NDPSC

National Drugs and Poisons Schedule Committee

NHMRC

National Health and Medical Research Council

NICNAS

National Industrial Chemicals Notification and Assessment Scheme

non-critical device

a device that only comes in contact with intact skin or does not come in contact with the human body.

non-proprietary name

the name used to describe the goods (particularly medicines) in a specific standard, including the name of the dosage form (if no standard exists, a name may comprise the AAN of the active ingredient and the name of the dosage form)

Top of page

O

OCM

TGA Office of Complementary Medicines

ODBT

TGA Office of Devices, Blood and Tissues

OLSS

TGA Office of Laboratories and Scientific Services (previously known as TGA Laboratories (TGAL))

OMQ

TGA Office of Manufacturing Quality (previously known as Manufacturers Assessment Branch (MAB))

OMSM

TGA Office of Medicines Safety Monitoring (previously known as Adverse Drug Reactions Unit (ADRU))

Open-but-unused

refers to a single use device where the packaging has been damaged or opened but the device not used and/or did not come in contact with blood, tissue or body fluids

ONPM

TGA Office of Non Prescription Medicines

OPM

TGA Office of Prescription Medicines (previously known as Drug Safety and Evaluation Branch (DSEB))

OTC

Over-the-Counter (medicines)

OTGs

Other therapeutic goods

Top of page

P-Q

pack size

the size of the goods in terms of the quantity contained in the container (e.g. volume in a multi-use container) and/or the number of items in the primary/unit pack (e.g. number of tablets in a bottle)

PH Eur

European Pharmacopoeia

principal manufacturer

the manufacturer who manufactures the goods or who performs one or more steps in the manufacture of the goods and also contracts with, or controls the use of other sub-manufacturers for the performance of the remaining steps in manufacture of the goods

Product Information (PI)

information relating to the safe and effective use of the goods, including information regarding the usefulness and limitations of the goods

PIC/S

Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme

PMF

Can mean Plasma Master File or Plant Master File depending on the context

potentially hazardous

in relation to a medical device, means that the basic risk of the device, before deliberate measures have been taken to minimise risk by inherent design or protection mechanisms, is considered intolerable

primary pack

the complete pack in which the goods, or the goods and their container, are to be supplied to consumers

procedure pack

see Australian Regulatory Guidelines for Medical Devices

prohibited representation

a representation referred to in subsection 42DJ(1) of the Act

proprietary ingredient

formulated ingredients, usually commercially obtained, for which the formulation may not be available to the sponsor of the final product (also see Notification of a proprietary ingredient)

proprietary name

the registered trademark of the therapeutic goods or the unique name assigned to the goods by the sponsor and appearing on the label

PSC

Pharmaceutical Subcommittee (of ADEC)

Top of page

Q

QA

quality assurance

QMS

Quality Management System

Top of page

R

recall

an action taken to resolve a problem with therapeutic goods for which there are established deficiencies in quality, efficacy or safety (see the Uniform Recall Procedure for Therapeutic Goods (URPTG)

refurbishment

is taken to have occurred if the medical device, or a part of the device, is substantially rebuilt from one or more used medical devices of that kind so as to create a medical device that is able to be used for the purpose originally intended by the manufacturer of the original device

Refurbishment of a medical device may involve the following actions:

  • stripping the device into component parts or sub assemblies
  • checking parts of the device for suitability for reuse
  • replacing component parts or sub assemblies of the device that are not suitable for reuse
  • assembling reclaimed or replacement component parts or sub assemblies of the device or another used device
  • testing a reassembled device against the specifications of the original device or, if the manufacturer has revised those specifications, the revised specifications
  • identifying an assembled device as a refurbished device

[the] Register

the Australian Register of Therapeutic Goods

registered goods

therapeutic goods included in the part of the ARTG for goods known as Registered goods

registered medicine

see Summary classification of medicines

registrable goods

goods that are required by the Act to be included in that part of the ARTG for Registered goods

registration number

see AUST R number

re-manufacture

refers to one or more of the following activities carried out on single use devices to supply for reuse:

  • Assembly the device; or
  • Packaging the device; or
  • Processing the device; or
  • Fully refurbishing the device; or
  • Labelling the device; or
  • Assigning the device a new intended purpose by means of information supplied by on or in the labelling; the instructions for use or advertising material

In the process, the person responsible for undertaking these activities on a single use device has:

  • Changed the intended purpose of the device;
  • Certified the device is suitable for reuse; and
  • Assumed the legal liability for the quality, safety and performance of the device

restricted representation

any reference expressly or by implication, to a disease, condition, ailment or defect specified in Table 1, Appendix 6 of the Therapeutic Goods Advertising Code (also see Restricted representations)

reuse

the repeated use or multiple use of any medical device which has undergone some form of reprocessing (cleaning, disinfection or sterilisation) between each episode of use

reusable device

a device designed or intended by the manufacturer as suitable for reprocessing and reuse. It is not a device that is designed or intended by the manufacturer for single use only.

route of administration

route by which a therapeutic good is applied on or introduced into the body

Top of page

S

SAS

Special Access Scheme

semi-critical device

a device is one that comes into contact with intact mucous membranes or broken skin. The device should be sterilised where possible, or high-level disinfected.

serious AE/ADR

see Guidelines on the reporting of adverse drug reactions by drug sponsors: Definitions

SIME

Strategic Information Management Environment - now called TGA eBusiness Services

single patient use

more than one episode of use of a medical device on one patient only, the device may undergo some form of reprocessing between each use in accordance with the manufacturers instructions for reuse on the same patient

single use

means the medical device is intended to be used on an individual patient during a single procedure and then discarded. It is not intended to be reprocessed and used on another patient.

Some single-use devices are marketed as non-sterile which require processing to make them sterile and ready for use. The manufacturer of the device will include appropriate processing instructions to make it ready for use

SMF

Site Master File

specified media

in relation to an advertisement or generic information, means:

  1. mainstream media within the meaning of Section 42B of the Act OR
  2. cinematograph films OR
  3. displays about goods, including posters
    1. in shopping malls (except inside an individual shop)
    2. in or on public transport
    3. on billboards

sponsor

in relation to therapeutic goods, means:

  1. a person who exports, or arranges the exportation of, the goods from Australia; or
  2. a person who imports, or arranges the importation of, the goods into Australia; or
  3. a person who, in Australia, manufactures the goods, or arranges for another person to manufacture the goods, for supply (whether in Australia or elsewhere);

but does not include a person who:

  1. exports, imports or manufactures the goods; or
  2. arranges the exportation, importation or manufacture of the goods;

on behalf of another person who, at the time of the exportation, importation, manufacture or arrangements, is a resident of, or is carrying on business in, Australia.

supply

includes supply by way of sale, exchange, gift, lease, loan, hire or hire purchase (it also includes whether free of charge or otherwise, samples or advertisements, supply for testing the safety or efficacy, and for treatment of person or animal)

SUSDP

Standard for the Uniform Scheduling of Drugs and Poisons

Symbol symbol meaning DO NOT REUSE:

The international recognised symbol described in ISO 15223:2007: - Medical devices - Symbols to be used with medical device labels, labelling and information to be supplied and means DO NOT REUSE. The synonyms for this symbol are "single use" or "use only once".

systems [regulated devices]

See Australian Regulatory Guidelines for Medical Devices

Top of page

T

tamper

therapeutic goods are tampered with if:

  1. they are interfered with in a way that affects, or could affect, the quality, safety or efficacy of the goods; and
  2. the interference has the potential to cause, or is done for the purpose of causing, injury or harm to any person.

TEP

Tamper-evident packaging

TERG

Manufacturing Technical Expert Reference Group. There are six reference groups:

  • Blood and Tissues Manufacturing Technical Expert Reference Group
  • Complementary Medicines Technical Expert Reference Group
  • Medical Devices Technical Expert Reference Group
  • Non-Sterile Medicines Technical Expert Reference Group
  • Pharmacy Manufacturing Technical Expert Reference Group
  • Sterile Medicines Technical Expert Reference Group

TGA

Therapeutic Goods Administration

TGACC

Therapeutic Goods Advertising Code Council

TGC

Therapeutic Goods Committee

TGO

Therapeutic goods order

therapeutic good

see How do I determine whether my product is a 'therapeutic good'?

therapeutic use

see How do I determine whether my product is a 'therapeutic good'?

Therapeutic Goods Advertising Code (TGAC)

see Therapeutic Goods Advertising Code

TICC

TGA-Industry Consultative Committee

topical

applied to a certain area of the skin for a localised effect

transdermal

applied to the skin for a systemic effect by the diffusion or continuous absorption of the active ingredient through the skin

traditional use

use of a designated active ingredient that is well-documented, or otherwise established, according to the accumulated experience of many traditional healthcare practitioners over an extended period; and accords with well-established procedures of preparation, application and dosage

TSE

transmissible spongiform encephalopathies

Top of page

U

URPTG

Uniform Recall Procedure for Therapeutic Goods

used

For medical devices that are supplied sterile:

  • the device has been placed into a wound or body cavity and comes into contact with blood or body fluids; or
  • has been opened but cannot be reprocessed because the manufacturer did not provide instructions on how to reprocess the device if the package is opened or damaged.

For medical devices that are supplied non-sterile:

  • the device has been applied for its intended purpose.

USP

United States Pharmacopoeia

Top of page

V-W-X-Y-Z

vital physiological process

of a patient, means a process that is necessary to sustain life and the indicators of which may include any 1 or more of the following:

  1. respiration
  2. heart rate
  3. cerebral function
  4. blood gases
  5. blood pressure
  6. body temperature

WHO

World Health Organization

Top of page